Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Dow
Express Scripts
Moodys
McKesson

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017441

See Plans and Pricing

« Back to Dashboard

NDA 017441 describes INFED, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from four suppliers. Additional details are available on the INFED profile page.

The generic ingredient in INFED is iron dextran. There are eighty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the iron dextran profile page.
Summary for 017441
Tradename:INFED
Applicant:Allergan Sales Llc
Ingredient:iron dextran
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017441
Mechanism of ActionPhosphate Chelating Activity
Suppliers and Packaging for NDA: 017441
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INFED iron dextran INJECTABLE;INJECTION 017441 NDA Allergan, Inc. 0023-6082 0023-6082-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0023-6082-10) > 2 mL in 1 VIAL, SINGLE-DOSE
INFED iron dextran INJECTABLE;INJECTION 017441 NDA Actavis Pharma, Inc. 52544-931 52544-931-02 10 VIAL, SINGLE-DOSE in 1 CARTON (52544-931-02) > 2 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG IRON/ML
Approval Date:Approved Prior to Jan 1, 1982TE:BPRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
McKinsey
Boehringer Ingelheim
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.